
Loading, please wait...

Loading, please wait...

Recent research identifies significant heated tobacco product risks that challenge the “reduced-risk” narrative. Specifically, a 2026 study by Landwehr KR et al. utilized 3D human airway models to assess HTP aerosols. The investigators compared three popular devices against traditional cigarette smoke and air controls. Consequently, the findings provide a clear picture of how these emissions affect human respiratory cells.
The study found that HTP emissions harbor numerous toxic chemicals. Although these devices generate fewer total particles than cigarettes, the average particle size is smaller. This allows deeper penetration into the lung tissue. Moreover, Ploom S and glo systems caused the highest levels of direct cellular damage. Specifically, these products decreased cell viability and weakened the airway's protective barrier. Therefore, the resulting increase in airway permeability could lead to heightened sensitivity to pathogens and allergens.
In contrast to traditional cigarettes, HTPs elicited a different biological response. While cigarette smoke caused the most significant inflammatory mediator release, HTPs altered gene expression extensively. For instance, IQOS produced the second-highest level of gene expression changes among all tested groups. Furthermore, the researchers observed that HTP exposure actually decreased mediator responses compared to clean air. However, this does not indicate safety; instead, it points toward an “alternative risk” profile that requires further investigation.
Medical professionals in India should note that the Prohibition of Electronic Cigarettes Act (PECA) 2019 bans Heat-Not-Burn products. Additionally, since HTPs deliver lower nicotine doses per puff, users often increase their total consumption. This habit leads to a higher cumulative intake of toxic chemicals. Therefore, clinicians must inform patients that these products remain harmful. Regulatory oversight and clear public health warnings are essential to prevent a new generation of nicotine addiction.
No. While they are marketed as reduced-risk, research shows they cause significant cellular damage and alternative health risks not seen with traditional smoking.
HTP aerosols decrease cell viability and damage the integrity of the airway barrier. This increase in permeability can make the respiratory system more vulnerable to external threats.
Because HTPs often deliver less nicotine per puff, users may increase their frequency of use. Consequently, this leads to a higher cumulative exposure to the toxins present in the aerosol.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Always consult a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Landwehr KR et al. The respiratory health effects of heated tobacco product aerosols in a primary human airway epithelial cell model. Nicotine Tob Res. 2026 Mar 23. doi: undefined. PMID: 41870505.
2. Prohibition of Electronic Cigarettes Act (PECA). Ministry of Health and Family Welfare, Government of India. 2019.
3. Davigo M. Toxicological and health effects of heated tobacco products. Inhalation Toxicology. 2026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study on 3D human airway models reveals that heated tobacco products cause direct cellular damage and are not safer alternatives to cigarette smoking....
5 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today